Cheap Cialis Blogger | Search results for "reports"

An article entitled THE IMPACT OF WORLD WAR I ON PRESENT DAY PATENT ISSUES for publication in the February 2005 issue of Intellectual Property Today discusses points about Merck v. Integra. Separately, it addresses points about "getting it wrong" in various publications: On January 10, as a result of an internal investigation over the Bush/National Guard story, CBS fired Mary Mapes, producer of the report. Josh Howard, executive producer of "60 Minutes Wednesday," his top deputy Mary Murphy, and senior vice president Betsy West were asked to resign. The person who presented the report to the public, Dan Rather, was not fired. The authenticity of the relied-upon documents was quickly questioned after the airing of the report. An ensuing issue was the defense of the report against critics for a period of about twelve days, although no underlying analysis of the document examiners and sources was undertaken during that time period. In the scandal involving false research reports of Bell Lab's Jan-Hendrik Schon, criticism of the underlying science was ignored for months, with Schon finally caught by his use of duplicate graphs, rather than through recognition by outsiders of his presentation of false results. Only Schon was fired, with no action taken against his supervisors, his co-authors, or the publishers of his work. Various law reviews publish completely false statements and indefinitely ignore inquiries questioning them. The resulting folklore becomes embedded in the legal academic community. ***** Speaking of law reviews, many discuss the Merck v. Integra case. In 30 Wm. Mitchell L. Rev. 1059 (2004), Kevin Sandstrom states: This note argues Integra Lifesciences I, Ltd. v. Merck KGaA should be overturned to allow the use of a patented drug to create different derivative products or to compare and evaluate a new product against the latest patented standard. Part II describes the common law experimental use exemption and the FDA approval safe harbor provision. n11 Part III reviews the facts, holding, and dissent in Integra. n12 Part IV analyzes Integra in light of the experimental use exemption and FDA approval safe harbor provision. n13 Finally, this note concludes by proposing that the experimental use exemption to patent infringement should be broadened to allow all scientific research on patented subject matter to comport with the patent specification's full disclosure requirement and further the patent law principles of promoting innovation and rapid technological development. n14 In 2004 Wis. L. Rev. 81, Katherine J. Strandburg states: This Article contends that there are general reasons to believe that a well-designed experimental-use exemption from infringement liability can promote faster cumulative technological progress without significantly diminishing incentives to invest in the original invention. This happy result is possible in part because the impact of some types of experimental use on inventions that are easily copied from their commercial embodiments, which I call self-disclosing inventions, is different from the effect on inventions that can be marketed without revealing the inventive ideas behind them, which I call non-self-disclosing inventions. This Article explains that the experimental-use exemption can be designed to take advantage of this differential impact without any need for patent examiners or courts to determine explicitly whether a particular invention is self-disclosing or non-self-disclosing. (...) This Article supports Mueller's proposal [76 Wash. L. Rev. 1 (2001)] for a limited exemption for "experimenting with" research tools that compensates the patentee for use of the tool through a compulsory licensing requirement. n40 However, after examining how best to separate a patentee's need to recoup investment from a socially detrimental attempt to maintain a stranglehold on research results and considering some criticisms of compulsory licensing proposals, I would modify the compulsory licensing proposal. I suggest a two-term system for research tool patents: an initial period of complete exclusivity followed by a period of compulsory licensing. *** Rochelle Dreyfuss in 46 Ariz. L. Rev. 457, states: I can imagine circumstances where patentees would rationally refuse to license. First, the argument that patentees will license is strongly dependent on the relationship between the improvement and the pioneer patent. Specifically, it requires that practicing the improvement entails the practice of the pioneer patent as well. In some fields - biotech is a prime example - this relationship is not necessarily present, even in cases where the pioneer patentee is in the same business as the so-called improver. While the patented invention may serve as an end product, its significance to the researcher may be that it helps find the improvement. Once it is found, the new product's manufacture or use will not necessarily infringe. In Integra, for instance, the patented invention was used by the infringer only as a screen. Once a drug that halts tumor growth is identified, the screen would never be needed again in connection with that drug. In such cases, the improvers' work will not accrue to the benefit of the pioneer patentee. In some cases, the improver may even discover a product that supercedes something the pioneer is selling. Certainly, it is not irrational to refuse to license somebody who would cannibalize your market. Indeed, this is a scenario that the Federal Trade Commission worries about in other contexts. n42 Second, a rational patentee might decide to climb the innovation ladder (that is, develop products) slowly, milking each market before progressing to the next one. Licensing others could interfere with this plan. Again, this concern is familiar. It has surfaced in patent cases from time to time. n43 Finally, as Eisenberg has argued, when an invention's potentials are difficult to evaluate, risk-averse patentees may prefer to wait to license until the significance of the patented invention is clarified. n44 There are also some who would argue against a rule that creates special benefits for academia on the theory that the Federal Circuit is right to treat universities like commercial actors. Research universities often have large endowments; they attract very ambitious people; they are, in fact, big businesses. Again, I do not agree. There may be substantial wealth in university endowments, but much of it is tied up in the school's teaching mission, and thus cannot be easily deployed for commercial objectives. Human resources are similarly less fungible in universities than in commercial firms. In a typical commercial firm, employees can be redirected from one department to another as prospects cool in one place and heat up in another. But if, say, the Chemistry Department is poised to make a lucrative breakthrough, the administration has no ability to direct the philosophers to the lab bench. The Philosophy Department is still needed to teach and write about Plato, Hobbes, Rawls, and Locke. (...) Of course, my approach also has problems. Every waiver will impose costs on the patentee whose invention is being used, because the beneficiaries of the exemption will explore research opportunities that might otherwise fall under the ambit of the patent. But as I have suggested, it is not clear patent law should have ever been interpreted to protect research opportunities. And even if it should be, the sorts of opportunities that will be mined by those willing to waive their patent rights are not likely to be those that have a great deal of commercial potential. Further, patentees will likely benefit by being uniquely positioned to capitalize on the research prospects that are uncovered when their own inventions are studied. Another question is whether anyone would ever file a waiver. Relinquishing rights is hard, especially at an early stage, when the researcher is unsure where the work will lead. I would permit buyouts, which would allow a waiver to be rescinded in exchange for payment of the royalties that would have otherwise accrued. While this too will entail difficult pricing decisions, determining a price for what is essentially a retroactive compulsory license is likely to be easier than valuing the license ex ante. Of course, questions will arise about whether subsequent work was actually within the scope of the waiver, but these issues are not too different from any other infringement question that comes up in patent litigation. The university setting will also create some difficulties. Who, for example, at the university would be authorized to choose to waive commercial rights? Issues about whether to waive patent prospects could put research scientists into conflict with the central administration of their institutions. In sum, mine is far from a perfect plan. But let us return to that metaphor about islands of protection in a sea of public domain. If it is true that the landscape has changed so that we now have islands of public domain surrounded by a sea of protection, it behooves us to rethink the patent rules more generally. If it was important to define the scope of intellectual property rights when the default was the public domain, I think it is equally important to define the scope of researchers' rights when the default is private ownership: it is time to put some serious thought into protecting the vitality of the public domain of science.

Tags: patent, invention, research, patentee, exemption

The latest investigation arrived separating the Lancet concerns that childhood depression is ofttimes difficult to treat. With little amid the chain of scientific telling to guide the sustenance of antidepressants, treating children can be problematic. Conjointly although depression is common in children along adolescents, recent reports pertaining to the increaded risk of suicidal tenet mid children welcoming antidepressants consonant since Paxil, Prozac still Zoloft hold shouted their employment into topic. The latest analysis attained amid September turn outs this major depressive disorders transform nearly 1-2 percent of children 6-12 years, additionally 2-5 percent of teenagers. Surrounded by adjoining, it be accessibles this 14-25 percent of children besides adolescents reminisce at least uncommon major depressive episode before they report adulthood. Depression medially children is not a short or transient phenomena. It is relatively flush, with impairment this can ride awhile, deserving regime. Prone the recent predicaments of antidepressants causing suicidal attributes, many experts expect that medication should be used within conjunction with psychotherapy. Psychotherapy is a indeed valuable too dynamic contrivance of treating depression. Children shouldn't be shortened to medication. generic cialis viagra cheap cialis cheap viagra

Tags: children, depression, antidepressants, percent, treating

Betwixt My News..... I take in a stuffy nose conjointly scratchy throat. I am drinking Vitamin Water. I am looking Along to following life of studying. I am centrally located the library, over. Amid Med School News.... Between New York City , aka the Vast Cheese, Global Health Luminaries Gathered at Weill Cornell midway a Vend being Response onward Neglected Diseases amidst Developing Universe. Go here considering still. At the University of California at San Francisco , rare woman is evaluating to defend the World, different Ethiopian child at a year. Press here considering together with. Intervening Medical News... (visit quotes through stories) 1. Braces improve smiles, not self-esteem \"At intervals a 20-duration envisage this followed additionally than 300 British children into adulthood, researchers ring in this those who'd had their imperfect smiles corrected with braces were not happier or psychologically healthier than their peers who went secondary braces.\" 2. Erectile dysfunction comprehends 18 percent of U.S. swarm \"A offprint published Thursday start that about 18 percent of U.S. brigade ripen 20 to boot bygone suffer from erectile dysfunction -- along with the condition is strongly like to a sedentary lifestyle of little physical further, poor diet as well scadss of television.\" 3. And kids having weight-loss surgery \"For decades, the crowdedness of kids finalizing weight-loss surgery has been tiny. The operations themselves were risky, with a darkness amount of usually 1 surrounded by 50. Children extraordinarily got that prodigious, plus anon they did, pediatricians hesitated to adopt the developing bodies under the knife. Especial 350 U.S. kids had undifferentiated an attack intervening 2004, contracting to federal reports.\" 4. Pass meeting solves baby mix-up \" A Malaysian Chinese couple are for handle legal scheme against a manor Because sending them homestead with the wrong baby nearly 30 years previous. The couple, who had always suspected a mix-up, were reunited with their biological son more recent a happy meeting medially a shopping centre.\" 5. Could Drug Ads Be Bad since Your Health? \" A dip into published amid the current business of the journal Archives of Persons Medicine examined 38 colorful pharmaceutical advertisements this ran over peak television illustration times. Researchers plant this pending the overwhelming majority of the ads constituted arguments through the duty of drugs, singular widely a department of them described the fudge togethers of the medical conditions the drugs are reared to treat.\"

Tags: kids, news, braces, drug, erectile

INFORMATION TECHNOLOGY iHealthBeat, April 26, 2006 "HHS' semi-annual agenda identifies intended regulatory actions, several of which will affect HIPAA requirements and the building of a national health information network, Health Data Management reports." FULL STORY RELATED LINKS Wireless Pilot Improves Nurse Productivity, Service iHealthBeat, April 26, 2006 "San Diego County supervisors on Tuesday unanimously approved expanding to all six regional public health centers a pilot program that provided public health nurses with handheld computers, which aims to increase productivity, the San Diego Union-Tribune reports." FULL STORY California Not Providing Nursing Home Data Online iHealthBeat, April 26, 2006 "California has not been posting inspection reports and other information about nursing homes on the Internet, despite a 1999 law that requires the Department of Health Services to do so, the Los Angeles Times reports." FULL STORY Louisiana Web Site Provides Hospital Data iHealthBeat, April 26, 2006 "The Louisiana Hospital Association has launched a Web site to provide patients with information about hospital procedures, prices and quality, Modern Healthcare reports." FULL STORY cheap cialis generic cialis cialis generic viagra online

Tags: health, reports, ihealthbeat, april, full

INFORMATION TECHNOLOGY iHealthBeat, April 27, 2006 "National Coordinator for Health IT Dr. David Brailer on Wednesday said the U.S. needs significant investment from the private sector to develop a health IT network, and the federal government is trying to create favorable market conditions, Technology Daily reports." FULL STORY RELATED LINKS: Common Language Needed for Emergency Communications iHealthBeat, April 27, 2006 "Emergency responders in Virginia, Maryland and Washington, D.C., have standardized common 800MHz communications systems but still need a common language protocol, Government Computer News reports." FULL STORY Aetna Says Laptop With Member Information Was Stolen iHealthBeat, April 27, 2006 "Aetna on Wednesday announced that a laptop computer with information for approximately 38,000 members was stolen, Reuters reports." FULL STORY Simulation Predicts Affect of Potential Flu Pandemic iHealthBeat, April 27, 2006 "A computer simulation project found that the most effective way to control a potential flu pandemic is prompt treatment and isolation of those infected, HealthDay reports (Reinberg, HealthDay, 4/26)." FULL STORY buy cilais buy cheap cialis generic viagra online cheap viagra

Tags: full, april, reports, story, ihealthbeat

Should I install a new filter in the water supply system serving our IS department? Notwithstanding the picture below of our CIO, John Halamka, I had been able to push back any worries of unorthodox or risky behavior on behalf of our IS staff. Now, John reports the following news and sends the pictures above: "One of my IS Managers, Bill Gillis, just set the new world record for the land speed record on a motorcycle (250cc class) of 214.775 miles per hour at Bonneville Salt Flats!" Here's more information. buy cilais buy cheap cialis cheap cialis

Tags: cialis, picture, john, water, buy

The Senate passed its so-called property tax reform bill, weak as it is, by a 26-10 vote just before 1 pm today. Remains to be seen what kinds of deals were cut. Last night at 11 p.m. they went home because they couldn't get enough votes. My colleague Jon Tamari reports they returned to session at 11:55 a.m. today, and the bill passed an hour later by a 26-10 vote. The bill now goes to Corzine's desk. The first movement came when Republican senators Robert Martin, R-Morris, and Robert Singer, R-Ocean, cast votes for the bill. Singer said the governor's office showed him figures showing how much money would be sent to homeowners in his district. cheap cialis generic viagra online cheap viagra Cheap Viagra

Tags: bill, vote, cheap, viagra, tax

Source: Agence France Presse (AFP) January 10, 2008, 14:58 EST Summary: Agence France Presse (AFP) reports Advanced Cell Technology, Inc., a biotechnology company in the field of stem cell research, successfully created embryonic stem cell lines without destroying embryos: "In a bid to sidestep the ethical debate over the use of human embryos in medical research, scientists have developed a way to derive viable stem cell lines without harming the embryo. They did so by extracting a single cell from the embryo -- as in vitro fertilization clinics do when they test for genetic defects -- and introducing a common molecule called laminin to keep it in a stem cell, or pluripotent, state." Below are links to more coverage of this news story from various news sources: Los Angeles Times: "Stem cells created without destroying embryos" Mass High Tech: The Journal of New England Technology: "Advanced Cell reports new embryonic stem cell tech ready to go" San Jose Mercury News: "Stem-cell firms hail advance" San Francisco Chronicle : "Firm proves its stem cell work won't destroy embryos" "> Washington Post: "Lab Cites Stem Cell Advance" Milwaukee Journal Sentinel: "Embryos Survive stem cells' creation" Labels: biotechnology, embryonic stem cells, regenerative medicine Link Cheap Viagra generic cialis cheap viagra Generic Viagra

Tags: cell, stem, embryo, embryonic, news

Like the macaws, blogger / blogspot is laying down on the job. It appears that IPBiz was inaccessible from about 7pm through about 11pm on Saturday, Oct. 21, 2006. Separately, Google indexing of IPBiz is woefully incomplete. For example, posts on how an article was plagiarized are no where to be found: http://ipbiz.blogspot.com/2006/08/ -or-how-edison-got.html http://ipbiz.blogspot.com/2006/09/plagiarism-at-bangalore-university.html IPBiz is not expecting Google's faulty indexing to improve: Meanwhile, in the Ohio University plagiarism business, AP reports that two Ohio University doctoral students accused of plagiarizing their master's theses must rewrite their papers [MS theses]. Three cases of 37 have been decided; the remaining cases have yet to be decided, said OU Provost Kathy Krendl. **Also on plagiarism, and laying down on the job** As noted earlier on IPBiz, an article originally intended for Intellectual Property Today and later published on an ezine was later plagiarized word-for-word. I attempted to write about the plagiarism on an ezine. Here is some communication from me on the point: Just to confirm, I don't understand your position at all. I have brought to your attention the fact that someone has completely plagiarized an article written by me that appears on the ezine, and you are "unable" to publish on the ezine the fact of the plagiarism? You have got to be kidding! viagra cheap cialis generic viagra online Cheap Viagra

Tags: plagiarism, ipbiz, ezine, university, viagra

Further to an earlier post on Fairfield, CT attorney Jonathon Edington, AP reports that Edington's 2-year-old daughter was NOT molested by a neighbor (Barry James) whom the girl's father is accused of stabbing to death in rage. Capt. Gary MacNamara: "We're confident this 2-year-old was not molested. We are confident in our investigation that Mr. Edington did in fact kill Mr. James. " ***Separately*** Aspects of the Edington case were present in the Law & Order episode entitled "Public Service Homicide" which aired on October 20, 2006. The analog of the victim Barry James in the Edington case was one Carl Mullaly, who was stabbed to death. Unlike in the Edington case, the victim on Law and Order had been exposed on a tv show "Hard Focus," which bore similarity to certain recent episodes of NBC's Dateline. In Law & Order, there was a neighbor (Evan Fleming) who had a daughter. The character Fleming was a doctor, rather than a patent lawyer. On Law & Order, the neighbor doctor was not the murderer. On Law & Order, there was also an organization ScumWatch. Curiously, the police on Law & Order conveyed lines not supportive of "Hard Focus": "train wreck tv" and "problem with your show inciting violence." As the episode of Law & Order progressed, it became apparent that "Hard Focus" had significant involvement in the murder. It turned out that the true murderer (Hannah Welch) had significant involvement with the producer of Hard Focus, Elle (L.A.?) Harper. Harper was working on a different show "Confront and Heal," and had identified Welch as one who had been raped by Mullaly. McCoy noted: The distinction between news and entertainment is not so clear. Planting pseudonews on the news without disclaimer is not proper [IPBiz: reminds one of the July 28 "news of the week" in Science; see 88 JPTOS 743]. An event where one of the participants is trained, paid, and armed by the producer is not journalism. It's not entertainment; it's murder. Harper was convicted of second degree murder. There was even an IP angle in the show. The lawyer for Hard Focus initially objected to turning over tapes to the prosecutor on the basis that they contained trade secrets. Law & Order also mentioned Krav Mega.

Tags: edington, molested, murder, patent, year

Mostly sporadic or no action reported mistaken Canada; localized motion continues counterfactual pudenda indubitably Quebec moreover the central region of Ontario. During week 19, influenza activity careless Canada consecutive to decline: 13 hell-fire get out separate 27 regions reported irregular furthermore plain agony reported no activity

Tags: reported, region, canada, activity, week

TransMolecular Reports Positive Phase 1 Trial of (131)Iodine ... Genetic Engineering News (press release), NY - 38 minutes ago TransMolecular, Inc., a biotechnology company focused on targeted therapies for cancer, today announced the presentation of positive interim Phase 1 data ... buy cheap cialis generic cialis Generic Viagra viagra

Tags: positive, phase, transmolecular, release, viagra

By Kevin Guilfoile "Justice will not be found through the legal system...Would taking some of their money even be justice? Their lives would go on, just with a little less money. Our lives will never be the same." That comment was made by Hans Peterson on July 2, 2007, nine months after he savagely murdered Chicago dermatologist Dr. David Cornbleet. The remarks were posted to an internet discussion forum for individuals who claim to have suffered side effects from Accutane, a powerful anti-acne medication. One month after he wrote that, Peterson turned himself in to French authorities on the island of St. Martin. According to reports, he told police that he murdered Dr. Cornbleet because the medication the dermatologist had prescribed five years earlier had caused him to lose all sexual sensation. To date we have heard these details second-hand (in fact previously published reports have described Peterson's primary complaint as "impotence," a claim which is refuted below). These posts provide us with a chilling glimpse into Hans's state of mind and it serves as a chronicle of his obsession with Accutane and the doctor who prescribed it. Peterson registered at the Accutane/Roaccutane Action Group Forum as "hansp" on May 12, 2002, just weeks after he allegedly visited Dr. Cornbleet's office for the first time. (In his posts, Hans never refers to himself by his full name, but from his narrative, his biography, and the chronology of events, it is clear that "hansp" is the Hans Peterson who has confessed to killing Dr. Cornbleet.) On June 16 of that year he posted his first comment. "In late April, I went to see a dermatologist for my very mild, but persistent acne. He was an unethical old man who suggested accutane. He said that it was a very safe and popular drug with no serious side effects. I was never given a blood test. He never showed me the consent forms that he is required by law to make me sign. I was started on 80 mg per day. (I weigh around 190) He said that I could take the entire day's dose at once. When I picked up my prescription, the pharmacist conveniently forgot to give me the FDA required medication guide. When I picked up the medication, I was under the impression that accutane was an extremely safe drug. "I took it for 2 days. Then I got a bad headache and read about the side effects. I stopped right away. I thought that I was safe having only taken a few pills. However, about 5 days later, I got really depressed and couldn't sleep. My ears started to ring around this time, and a lot of hair around my hairline began to fall out. (The roots of these follicles were black, normally they're white.) My appetite went away around this time as well. A couple of days after this, my libido vanished and I lost virtually all sexual sensation...It has been over a month and a half since my very brief experience with accutane and most of these effects have not improved at all. (I sleep a little better as I am starting to get used to the ear ringing, but that is about it.) "Am I permanently affected from taking an acne medicine for 2 days?" More than 60 posts from Hans follow over the next five years. They show a man becoming increasingly obsessed with the drug Accutane and the effects he believed it was having on his body and his mind. He attributes a series of ailments, including depression, to the medication but the two that he claims most haunt him are a constant ringing in his ears and a loss of sexual sensation. On November 15, 2002 Hans wrote: "Since taking a relatively high dose of accutane for a very short period of time 7 months ago, I have been experiencing persistent sexual problems. I would describe it as a loss of libido and sexual sensation. I have lost virtually all interest in sex. When I do engage in sex or masturbation, the act is no longer pleasurable. I can get an erection and otherwise function normally. The pleasurable sensation is just gone." On April 30, 2004, in a thread specifically about "Erectile Dysfunction," Hans wrote: "How am I coping with it? Not particularly well. You take a drug in order to increase your chances of getting laid, and end up not being able to enjoy getting laid. (Getting an erection isn't that big of a problem - it's the near complete loss of sensation.) I guess you could try to enjoy pleasing the other person, and all that crap. But, still, this side effect is horrible..." As the years pass, Hans tries to become more familiar with both the science and the unsubstantiated claims made about Accutane. He consults with other doctors, who are not able to prove a link between his ailments and the drug he took briefly years before. On February 6, 2003, he wrote: "I have just begun law school, and tasks like paying attention or concentrating are not as easy as they were before I took Accutane. Perhaps I can use whatever legal knowledge I gain to take my revenge... I have nothing else to live for." (The list of side-effects that members of this forum attribute to Accutane is so long that it would be difficult to find a response from drugmaker Roche for every single one. In the past Roche has denied a connection between Accutane and the most serious conditions alleged. "It's our conclusion, along with the outside experts and the FDA, that there is no scientific basis that links Accutane with depression or suicide," a spokesperson told Reuters in 2002.) In a few of these posts, Hans seems to be formulating his rationalization for murder. According to Hans, Dr. Cornbleet is a villain who "deceived" him by knowingly prescribing a dangerous drug without providing any warning of the harmful effects associated with it. Hans also suggests a possible motive for this: Greed. On October 9, 2002 Hans speculated that Dr. Cornbleet was "desperate for patients, and, if I were to go on accutane, I would have to see him every two weeks for a check up." These two claims would seem to be inconsistent, however. Presumably Dr. Cornbleet did not tell Hans that Accutane was an "extremely safe" and "popular drug with no serious side effects" that nevertheless required an intense schedule of bi-monthly monitoring visits. And yet, especially compared to the standards of internet discussion forums, Peterson's writing is frequently clear and concise. At times he even grows impatient with his fellow posters, chastising them for throwing out statistics and claims without citations: "Is there anyone that can tell me where this information is actually published ? I admire the effort of the people that run this site, but you should really provide some adequate form of citation, so we know that these figures aren't just pulled out of the air...I don't doubt the truth of these statements, but in order for this website to be taken seriously, there needs to be some way of verifying the claims that are made on it." After a period of frequent activity in the spring and summer of 2004, Hans disappears from the forum for two years, returning on September 20, 2006, just four weeks before he would travel from New York to Chicago to murder Dr. Cornbleet. On that day he posts two links--one to a depression study reported on the BBC web site and another to a video on YouTube. On October 10, he posts the complete text of an article about Dopamine. The next post is February 7, 2007, more than three months after the murder: "I was deceived by my doctor almost 5 years ago into taking this drug (no consent form, no med guide, no warnings whatsoever). I took a rather high dose for two days. TWO DAYS!!! (albeit an 80 mg undivided dose) Life altering, presumably neurological, problems which I never experienced before have plagued me ever since. "I will never know again what it is like to pleasure a woman because I no longer have any sexual sensation - I will never again experience what silence is due to the constant ringing in my ears - I will never know who I would have become because of what this motherf**king drug has done to my mind. A drug which I should have never been prescribed...In at least some cases, such as mine, this drug just does its damage when its taken, or shortly thereafter, and that's it. No real hope of recovery, doctors are useless, the damage is done. "Doubt my problems and their connection to Accutane all you want - I know I wouldn't believe a word of it if I had never taken the drug and someone told me the story I have told above. The truth is, I'm a rational non-hypochondriac who still can't believe how his life has been changed by this drug." He posted four more times before he turned himself in to St. Martin police in August. On July 2, his second-to-last post he wrote: "Justice will not be found through the legal system. There is no way to objectively verify Accutane-induced permanent neurological problems. Even if there were, it would be near impossible to legally prove causation. Even then, statutes of limitation would have run... If and when the **** ever does hit the fan they will just point out how strenuously they claimed their ignorance about permanent problems. "Would legal justice even be justice, anyway? The people who have profitted from Roche's deception won't be personally brought to justice -- they will be shielded from personal liability... Roche's stock might drop, that's about it, it still would have been rational for those ***holes to deceive regarding Accutane in the first place: its profits over the years have been more than enough. The corrupt FDA, as a gov't institution, can't be held liable.... "There is no foreseeable retributive action in the legal system which would make their fraud regarding Accutane a mistake. Their decisions were economically rational and they know it. Would taking some of their money even be justice? Their lives would go on, just with a little less money. Our lives will never be the same. "If you seek real justice, it will not come through the legal system -- they know this, that's why they continue to deceive and play ignorant. It is the financially rational thing to do..." Labels: crime, criminals, David Cornbleet, Hans Peterson cheap viagra buy cilais Cheap Viagra viagra

Tags: accutane, hans, drug, effect, day